$973M
$7.35 Million
0.01% of portfolio
864,123
Q2 2025
Reduced 44.67%
$3.36B
$9.78 Million
0.01% of portfolio
279,661
Q2 2025
Reduced 9.19%
$4.54B
$11.8 Million
0.01% of portfolio
172,931
Q2 2025
Reduced 0.08%
$2.08B
$10.1 Million
0.01% of portfolio
628,398
Q2 2025
Added 9.26%
$7.95B
$16.3 Million
0.01% of portfolio
314,469
Q2 2025
Added 586.25%
$4.09B
$7.49 Million
0.01% of portfolio
737,938
Q2 2025
Reduced 72.85%
$1.51B
$579,000
0.0% of portfolio
9,329
Q2 2025
Added 64.68%
$206M
$338,000
0.0% of portfolio
68,813
Q2 2025
Reduced 20.85%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 11.79%
$297M
$1.08 Million
0.0% of portfolio
703,117
Q2 2025
Added 308.67%
$199M
$78,000
0.0% of portfolio
21,135
Q2 2025
Reduced 16.59%
$202M
$1.08 Million
0.0% of portfolio
549,212
Q2 2025
Reduced 3.39%
-
$0
0.0% of portfolio
-
Q2 2025
Added 5.16%
$204M
$1.33 Million
0.0% of portfolio
186,215
Q2 2025
Reduced 45.18%
$1.3B
$412,000
0.0% of portfolio
21,340
Q2 2025
New
Aa Mission Acquisition Corp
-
$0
0.0% of portfolio
-
Q1 2025
Added 3.5%
Aa Mission Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
$4.41B
$3.36 Million
0.0% of portfolio
45,550
Q2 2025
Reduced 52.03%
$2.76B
$3.98 Million
0.0% of portfolio
57,842
Q2 2025
Added 37.0%
$229B
$854,000
0.0% of portfolio
6,279
Q2 2025
Reduced 63.35%
$1.22B
$175,000
0.0% of portfolio
51,074
Q2 2025
New
$5.03B
$4.68 Million
0.0% of portfolio
56,488
Q2 2025
Reduced 48.6%
-
$0
0.0% of portfolio
-
Q3 2023
New
Above Food Ingredients Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
New
$276M
$46,000
0.0% of portfolio
17,908
Q2 2025
New
$1.06B
$2.51 Million
0.0% of portfolio
98,549
Q2 2025
Reduced 12.13%
$358M
$2.91 Million
0.0% of portfolio
813,268
Q2 2025
Added 19.88%
$138M
$2.46 Million
0.0% of portfolio
1,793,391
Q4 2024
Added 5.38%
$109M
$3.98 Million
0.0% of portfolio
2,800,282
Q2 2025
Reduced 4.9%
$380M
$208,000
0.0% of portfolio
4,873
Q2 2025
Reduced 30.28%
$5.43B
$4.58 Million
0.0% of portfolio
62,876
Q2 2025
Added 12.02%
$1.28B
$2.25 Million
0.0% of portfolio
238,635
Q2 2025
Reduced 37.45%
$1.82B
$1.2 Million
0.0% of portfolio
10,418
Q2 2025
Reduced 79.61%
$1.02B
$567,000
0.0% of portfolio
62,092
Q2 2025
Reduced 82.87%
$25.6M
$13,000
0.0% of portfolio
22,199
Q2 2025
Reduced 95.61%
$7.31B
$377,000
0.0% of portfolio
44,563
Q2 2025
Reduced 98.57%
$5.76B
$5.32 Million
0.0% of portfolio
41,848
Q2 2025
Reduced 32.6%
$11.4B
$929,000
0.0% of portfolio
8,092
Q2 2025
Reduced 92.09%
$5.93B
$5.79 Million
0.0% of portfolio
43,676
Q2 2025
Added 4.1%
$94.9M
$996,000
0.0% of portfolio
222,399
Q2 2025
Reduced 4.84%
$530M
$2.24 Million
0.0% of portfolio
94,172
Q2 2025
Reduced 54.65%
-
$0
0.0% of portfolio
-
Q3 2022
Added 125.2%
Adverum Biotechnologies Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.71%
$16.9B
$1.52 Million
0.0% of portfolio
13,425
Q2 2025
Reduced 89.44%
$6.26B
$845,000
0.0% of portfolio
2,967
Q2 2025
New
$454M
$430,000
0.0% of portfolio
71,565
Q2 2025
Reduced 47.63%
-
$0
0.0% of portfolio
-
Q2 2025
Added 159.88%
-
$0
0.0% of portfolio
-
Q1 2023
Added 568.18%
$649M
$5.45 Million
0.0% of portfolio
305,059
Q2 2025
Added 31.81%